Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Its currently available as a prescription medication for the management of lipodystrophy
Store at -20C
In STEP 1, 1,961 nondiabetic adults with overweight or obesity achieved an average 14.9% weight loss over 68 weeks when semaglutide was combined with lifestyle changes.20 STEP 2 examined 1210 individuals with T2DM and showed a more modest average weight loss of 9.6%, possibly due to insulin resistance and the influence of other diabetes medications.21 STEP 3 introduced a more intensive lifestyle intervention to participants who were overweight or obese but without T2DMincluding a calorie-restricted diet and behavioral supportand resulted in slightly higher weight loss amongst the 611 study participants, averaging around 16%.22 The STEP 4 trial included 811 individuals who were overweight or obese without diabetes and assessed the impact of discontinuing semaglutide after 20 weeks
PT-141, the synthetic melanocortin peptide also called Bremelanotide, acts centrally on melanocortin-3 and melanocortin-4 (MC4R) receptors in the hypothalamus to increase sexual desire
BAC water allows researchers to reconstitute the entire vial and withdraw smaller amounts over several weeks without the solution becoming a breeding ground for microbes
)
